LGALS3 Is a Poor Prognostic Factor in Diffusely Infiltrating Gliomas and Is Closely Correlated With CD163+ Tumor-Associated Macrophages.

Hu, Wan-Ming; Yang, Yuan-Zhong; Zhang, Tian-Zhi; Qin, Chang-Fei; Li, Xue-Nong

Hu, Wan-Ming; Yang, Yuan-Zhong; Zhang, Tian-Zhi; Qin, Chang-Fei; Li, Xue-Nong.

Afiliação

Hu WM; Department of Pathology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
Yang YZ; Department of Pathology, Sun Yat-sen University Cancer Center and State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Zhang TZ; Department of Pathology, Sun Yat-sen University Cancer Center and State Key Laboratory of Oncology in South China and Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
Qin CF; Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
Li XN; Department of Pathology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.

Front Med (Lausanne) ; 7: 182, 2020.

Article em En | MEDLINE | ID: mdl-32528967

Palavras-chave

1p/19q; IDH; LGALS3; TAM; TERT; glioblastoma; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google